Works matching IS 18628346 AND DT 2023 AND VI 17 AND IP 1

Results: 9

Research progress in protein microarrays: Focussing on cancer research.

Published in:

Proteomics - Clinical Applications, 2023, v. 17, n. 1, p. 1, doi. 10.1002/prca.202200036

By:

Chen, Guang;
Yang, Lina;
Liu, Guoxiang;
Zhu, Yunfan;
Yang, Fanghao;
Dong, Xiaolei;
Xu, Fenghua;
Zhu, Feng;
Cao, Can;
Zhong, Di;
Li, Shuang;
Zhang, Huhu;
Li, Bing

Publication type:

Article

Proteomics of azoospermia: Towards the discovery of reliable markers for non‐invasive diagnosis.

Published in:

Proteomics - Clinical Applications, 2023, v. 17, n. 1, p. 1, doi. 10.1002/prca.202200060

By:

Rusevski, Aleksandar;
Plaseska‐Karanfilska, Dijana;
Davalieva, Katarina

Publication type:

Article

Proteomic and lipidomic biomarkers in the diagnosis and progression of inflammatory bowel disease – a review.

Published in:

Proteomics - Clinical Applications, 2023, v. 17, n. 1, p. 1, doi. 10.1002/prca.202200003

By:

Cecerska‐Heryć, Elżbieta;
Ronkowski, Bartosz;
Heryć, Rafał;
Serwin, Natalia;
Grygorcewicz, Bartłomiej;
Roszak, Marta;
Galant, Katarzyna;
Dołęgowska, Barbara

Publication type:

Article

Tandem mass tag‐based quantitative proteomic analysis of cervical cancer.

Published in:

Proteomics - Clinical Applications, 2023, v. 17, n. 1, p. 1, doi. 10.1002/prca.202100105

By:

Aljawad, Mohammed F.;
Faisal, Abdul Hussein M. Al;
Alqanbar, Mohammed F.;
Wilmarth, Phillip A.;
Hassan, Basima Q.

Publication type:

Article

Development of multiple reaction monitoring (MRM) assays to identify Brucella abortus proteins in the serum of humans and livestock.

Published in:

Proteomics - Clinical Applications, 2023, v. 17, n. 1, p. 1, doi. 10.1002/prca.202200009

By:

Husain, Aliabbas A.;
Pinto, Sneha M.;
Subbannayya, Yashwanth;
Kapoor, Saketh;
Khulkhule, Payal;
Bhartiya, Nidhi;
Prasad, T. S. Keshava;
Daginawala, Hatim F.;
Singh, Lokendra R.;
Kashyap, Rajpal Singh

Publication type:

Article

Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non‐responders' tumor tissue.

Published in:

Proteomics - Clinical Applications, 2023, v. 17, n. 1, p. 1, doi. 10.1002/prca.202100116

By:

Babic, Tamara;
Lygirou, Vasiliki;
Rosic, Jovana;
Miladinov, Marko;
Rom, Aleksandra Djikic;
Baira, Eirini;
Stroggilos, Rafael;
Pappa, Eftychia;
Zoidakis, Jerome;
Krivokapic, Zoran;
Nikolic, Aleksandra

Publication type:

Article

Masthead: Proteomics 1'23.

Published in:: Proteomics - Clinical Applications, 2023, v. 17, n. 1, p. 1, doi. 10.1002/prca.202370013
Publication type:: Article

Editorial Board: Proteomics 1'23.

Published in:: Proteomics - Clinical Applications, 2023, v. 17, n. 1, p. 1, doi. 10.1002/prca.202370012
Publication type:: Article

Front Cover.

Published in:: Proteomics - Clinical Applications, 2023, v. 17, n. 1, p. 1, doi. 10.1002/prca.202370011
Publication type:: Article